Malaysia’s push to build more home-grown technology champions is gaining a fresh injection of capital, this time across three very different but strategically important areas: warehouse automation, medical technology commercialisation, and assistive digital tools for the visually impaired.
VentureTECH, a Malaysian government-backed impact investment company, has invested US$7 million in three Bumiputera-led high-growth, high-value companies: Move Robotic, Recove Group, and Edote.
The investments come as Malaysia tries to deepen local participation in advanced industries, not merely as a consumer of imported technologies but as a builder of solutions that can serve domestic needs and eventually regional markets. For Southeast Asia, where many countries face similar challenges around industrial productivity, healthcare access, and digital inclusion, the bet is also about whether locally developed technologies can scale beyond national borders.
Also Read: Malaysia’s unicorn hunters: The startups raising millions and scaling fast
VentureTECH said the three companies were selected for their differentiated technologies, scalable business models, and commercial potential. The broader aim is to support Bumiputera companies that can contribute to Malaysia’s industrial competitiveness while delivering measurable socio-economic impact.
“At VentureTECH, we invest in companies with innovative technologies that solve real-world challenges, strengthen strategic industries and have the potential to scale sustainably,” said VentureTECH CEO Azizan Jaafar. He added that Move Robotic, Recove, and Edote represent the kind of companies the firm wants to back: commercially promising businesses that also address national development priorities.
The capital is also aligned with Malaysia’s Bumiputera Economic Transformation Plan 2035, or PuTERA35, which seeks to strengthen Bumiputera participation in higher-value economic activities.
Making automation easier to adopt
Among the three investees, Move Robotic addresses a pain point that is becoming more urgent across Southeast Asia: how businesses can automate warehouses and logistics operations without taking on large upfront costs or stitching together disconnected systems.
The company provides a warehouse and logistics automation ecosystem that combines Autonomous Mobile Robots, autonomous material-handling systems, Automated Storage and Retrieval Systems, pallet shuttle systems, and software tools such as its Warehouse Management System and Robot Fleet Manager.
In simple terms, this means Move Robotic is not just selling robots. It is trying to provide the hardware and software layer needed to help warehouses move, store, track, and retrieve goods more efficiently.
That matters in a region where e-commerce, third-party logistics, electronics manufacturing, and cold-chain distribution are all expanding. Many operators want to automate but face barriers such as high capital expenditure, uncertain integration timelines, and a shortage of in-house robotics expertise.
Move Robotic’s robot-as-a-service model is designed to reduce that friction. Instead of buying equipment outright, customers can adopt automation through a bundled subscription that includes implementation and ongoing use. The company aims to become Malaysia’s first provider of a fully bundled Robot-as-a-Service solution.
The model mirrors a wider shift in industrial automation globally, where manufacturers and logistics operators increasingly prefer usage-based or service-based systems rather than heavy one-off purchases. For Malaysia, having a local provider could also reduce dependence on foreign vendors and make customisation easier for domestic industries.
Turning medical research into market-ready products
Recove Group operates in a different but equally difficult part of the innovation chain: bringing healthcare research out of universities and laboratories and into hospitals, clinics, and patient care.
The company describes itself as a medtech commercialisation platform. It works with universities, researchers, and medical specialists to develop research-driven healthcare innovations into market-ready medical technologies.
Also Read: “Data, not hardware, is the real bottleneck in humanoids”: Matrix Robotics CEO Allen Zhang
This is a familiar bottleneck across Southeast Asia. Universities and hospitals often produce promising medical research, but many inventions fail to reach the market because researchers lack access to regulatory expertise, product development support, manufacturing partners, distribution channels, or commercial capital.
Recove’s role is to close that gap. One of its commercialised products is NEORUBIN, a non-invasive newborn jaundice screening device. Jaundice is common among newborns, and early screening is important to prevent complications. Non-invasive tools can help reduce discomfort for infants while allowing healthcare workers to screen more efficiently.
With VentureTECH’s investment, Recove plans to accelerate product commercialisation and advance additional medical technologies in its pipeline. If successful, the company could become part of a broader effort to build a stronger medical device industry in Malaysia, where healthcare demand is rising alongside an ageing population, higher chronic disease burden, and growing expectations for affordable care.
For Southeast Asia, medtech commercialisation has regional relevance. Many markets in the region face similar healthcare access issues, especially outside major cities. Locally developed devices that are affordable, practical, and designed around regional clinical workflows may stand a better chance of adoption than imported solutions built for very different health systems.
Digital inclusion for the visually impaired
The third company, Edote, focuses on assistive technology for the visually impaired community. Its flagship product, eBrelle, is described as the first standalone Braille laptop in Malaysia and Southeast Asia.
The device allows visually impaired users to access, create, and interact with digital content independently. Edote has integrated proprietary hardware, software, and accessibility-focused applications into a single platform.
The problem it is trying to solve is both social and economic. Digital tools are now central to education, employment, government services, and everyday communication. Yet many visually impaired people still face barriers in accessing mainstream technology, particularly when devices are expensive, poorly localised, or require multiple add-ons to function effectively.
By developing a standalone Braille laptop, Edote is attempting to make digital participation more practical and self-directed. VentureTECH said its support will help the company expand manufacturing capabilities, strengthen its product portfolio, and reach more users in Malaysia and across the region.
The opportunity is not limited to Malaysia. Across Southeast Asia, assistive technology remains underdeveloped, despite large populations of people with disabilities and rising policy attention on inclusion. If Edote can balance affordability, durability, localisation, and distribution, it could address a market that has often been overlooked by mainstream consumer technology companies.
Capital with a policy purpose
VentureTECH’s investment is not a conventional venture capital bet based purely on financial upside. As a government-backed impact investor, its mandate includes strengthening strategic industries and supporting companies that can deliver broader economic value.
That dual mandate is increasingly visible across Southeast Asia, where governments are using capital, procurement, grants, and policy frameworks to nudge domestic companies into higher-value technology sectors. The challenge is ensuring that such support produces companies that can compete commercially, not just survive through policy protection.
Also Read: China builds robot armies while the West chases robot brains
For Move Robotic, Recove, and Edote, the test will be execution: converting capital into stronger products, wider adoption, and regional market access. Each operates in a sector with clear demand, but also with long sales cycles, integration challenges, regulatory hurdles, or affordability constraints.
Azizan said VentureTECH’s role goes beyond providing funding. The firm works with investee companies to strengthen capabilities, unlock market opportunities, and scale sustainably.
That hands-on support could prove important. Malaysia has no shortage of technical talent or research output, but turning innovation into exportable companies remains a long-term task. By backing three Bumiputera-led firms in sectors tied to industrial productivity, healthcare, and inclusion, VentureTECH is placing a targeted wager: that the next generation of Malaysian technology companies can be both commercially viable and socially useful.
Whether these companies can move from national promise to regional relevance will determine the true impact of the investment.
The post Malaysia’s VentureTECH backs Move Robotic, Recove and Edote with US$7M appeared first on e27.
